Disease/Infection News

RSS

UCLA announces participation in a phase 3 trial evaluating tecovirimat for the treatment of monkeypox

The UCLA Clinical AIDS Research and Education (CARE) Center today announced its participation in STOMP (Study of Tecovirimat for Human Monkeypox Virus), or A5418, a phase 3, randomized, placebo-controlled, double-blind trial evaluating the safety and efficacy of tecovirimat for the treatment of human monkeypox.

16 Sep 2022

UW Medicine researchers seek participants for Phase 3 clinical trial of a drug to treat monkeypox

UW Medicine researchers are recruiting participants for a Phase 3 clinical trial of a drug to treat the monkeypox virus.

16 Sep 2022

Experts recommend nuanced messaging and accurate communication on zoonotic spillover risk

COVID-19 has been the first pandemic that has taken place alongside the interconnectivity of the Internet. Consequently, the spread of ideas and information about the disease has been unprecedented - but not always accurate.

16 Sep 2022

Antibody drugs are not recommended for patients with covid-19, say WHO experts

The antibody drugs sotrovimab and casirivimab-imdevimab are not recommended for patients with covid-19, says a WHO Guideline Development Group of international experts in The BMJ today.

16 Sep 2022

Intermittent movement behavior at large, crowded events increases disease transmission risk

What is the typical movement behaviour of visitors to large events, such as concerts, and what does this mean for the risk of spreading infectious diseases like COVID-19?

16 Sep 2022

Mucus-based prophylactic gel protects against HIV and herpes transmission

A mucus-based prophylactic gel developed at KTH Royal Institute of Technology has proven 70 percent effective in lab tests against HIV, and 80 percent effective against herpes.

16 Sep 2022

U of A research findings could give scientists the upper hand in tackling SARS-CoV-2

University of Alberta research shows how cell membranes play a much larger role than previously understood in allowing spike proteins on viruses to infect cells.

16 Sep 2022

University of Arkansas receives NIST award to improve palm-sized, low-cost and wireless COVID sensor

The National Institute of Standards and Technology, via an application from the RAPID Manufacturing Institute, awarded the University of Arkansas $699,604 to improve a Wi-Fi nano-biosensor that will be used in a palm-sized, low-cost and wireless SARS-COV-II detection system.

16 Sep 2022

New genomic test can predict a patient's risk of developing severe COVID-19, research suggests

A genomic test being developed by a Charlottesville, Va., company can predict a patient's risk of developing severe COVID-19, new research from UVA Health suggests.

16 Sep 2022

Genomic sequencing reveals the course of COVID-19 in Africa

A new study explores the contribution of genomic sequencing to the scientific understanding of COVID-19, and on the introduction of global public health measures via the ability to pick up new variants early enough.

16 Sep 2022

SARS-CoV-2 N escape mutations do not affect rapid antigen testing

A new study maps the escape mutations found in various strains of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could cause them to escape neutralization by antibodies or detection by rapid antigen tests that rely on antibody binding for a positive result.

16 Sep 2022

FAU researchers explore the impacts of COVID-19 pandemic on resident physicians

The COVID-19 pandemic has had many deleterious consequences for health care workers, including the challenges of caring for severely ill patients. Resident physicians, in particular, may have been affected by physical as well as psychological consequences of the pandemic. At present, data are sparse on the perceptions, coping strategies and mental health of residents during COVID-19.

16 Sep 2022

SARS-CoV-2 infection and vaccination results in highest and longest-lasting antibody response

A prospective seroprevalence study in the Catalan population underlines the need to get vaccinated despite having been infected and confirms that hybrid immunity (vaccination plus infection) is more robust and long-lasting.

16 Sep 2022

One year later, 40% of patients with COVID pneumonia still had lung problems

A recent study published in the journal Respiratory Research found impaired lung function and dyspnea amongst severe COVID-19 pneumonia survivors one year post-infection. Meanwhile, many COVID-19 patients developed fibrotic-like sequelae as an aftermath of the infection-associated mild or severe pneumonia.

15 Sep 2022

Study untangles the relation between bacteria and the environment in Lyme disease ecology

Predicting Lyme disease hotspots can help public health officials guide resources and proactive messaging to the public.

15 Sep 2022

Study explores new-onset tinnitus after COVID-19 vaccination

In a new study, researchers assessed the incidence of new-onset tinnitus after coronavirus disease 2019 (COVID-19) vaccination.

15 Sep 2022

Survey highlights increase in the public's knowledge about monkeypox

The public's knowledge about monkeypox has increased rapidly in recent weeks though misconceptions and uncertainty persist, and over a quarter of Americans say they are not likely to get vaccinated against monkeypox if they're exposed to it, according to a new Annenberg Public Policy Center (APPC) survey.

15 Sep 2022

COVID-19 vaccine safety concerns result in lower vaccination rates among pregnant individuals in the United States

In a new study, researchers evaluated the factors associated with lower coronavirus disease 2019 (COVID-19) vaccination rates among pregnant individuals in the United States (U.S.).

15 Sep 2022

CDC endorses ACIP recommendations for use of updated COVID-19 boosters

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendations for use of updated COVID-19 boosters from Pfizer-BioNTech for people ages 12 years and older and from Moderna for people ages 18 years and older.

15 Sep 2022

Study reveals pan-antiviral properties of PDC-109 bovine seminal plasma protein

In a new study, researchers explored the antiviral activity of the bovine seminal plasma protein PDC-109 against various mammalian viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

15 Sep 2022

Disease/Infection News

UCLA announces participation in a phase 3 trial evaluating tecovirimat for the treatment of monkeypox

UW Medicine researchers seek participants for Phase 3 clinical trial of a drug to treat monkeypox

Experts recommend nuanced messaging and accurate communication on zoonotic spillover risk

Antibody drugs are not recommended for patients with covid-19, say WHO experts

Intermittent movement behavior at large, crowded events increases disease transmission risk

Mucus-based prophylactic gel protects against HIV and herpes transmission

U of A research findings could give scientists the upper hand in tackling SARS-CoV-2

University of Arkansas receives NIST award to improve palm-sized, low-cost and wireless COVID sensor

New genomic test can predict a patient's risk of developing severe COVID-19, research suggests

Genomic sequencing reveals the course of COVID-19 in Africa

SARS-CoV-2 N escape mutations do not affect rapid antigen testing

FAU researchers explore the impacts of COVID-19 pandemic on resident physicians

SARS-CoV-2 infection and vaccination results in highest and longest-lasting antibody response

One year later, 40% of patients with COVID pneumonia still had lung problems

Study untangles the relation between bacteria and the environment in Lyme disease ecology

Study explores new-onset tinnitus after COVID-19 vaccination

Survey highlights increase in the public's knowledge about monkeypox

COVID-19 vaccine safety concerns result in lower vaccination rates among pregnant individuals in the United States

CDC endorses ACIP recommendations for use of updated COVID-19 boosters

Study reveals pan-antiviral properties of PDC-109 bovine seminal plasma protein

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News